GLP-1 treatments
Mounjaro treatment in Romania
Tirzepatide — a dual GIP/GLP-1 agonist for weight loss and type 2 diabetes. Online consultation with Dr. Petrache.
What is Mounjaro?
Mounjaro contains tirzepatide, a substance that acts on the GIP and GLP-1 receptors involved in regulating blood glucose and appetite.
In the European Union, Mounjaro is indicated for type 2 diabetes and weight management under the conditions of its authorisation. For weight management, it is used in eligible adults alongside a reduced-calorie diet and physical activity.
This page explains general information and access to an assessment; it does not determine whether the treatment is suitable for you.
How tirzepatide works
Tirzepatide activates the GIP and GLP-1 receptors. Acting on these pathways may reduce appetite and contribute to blood glucose control. The mechanism does not guarantee any particular individual result.
Benefits and risks are discussed after reviewing your medical history. Consult the official EMA information on Mounjaro for current indications and precautions.
Indications — who is Mounjaro for?
Mounjaro is indicated for two main categories of patients:
Weight management
Adults with obesity (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) with at least one weight-related comorbidity, such as:
- High blood pressure
- Dyslipidaemia (high cholesterol)
- Obstructive sleep apnoea
- Cardiovascular disease
Type 2 diabetes
Mounjaro is also indicated for insufficiently controlled type 2 diabetes under the current Summary of Product Characteristics. This is distinct from the weight management indication.
- The doctor checks the indication and concomitant treatment.
- Do not replace or stop insulin without your doctor’s recommendation.
What to discuss before treatment
Assessing eligibility is an essential step before starting treatment. Dr. Petrache will review your medical history in detail during the online consultation to determine whether Mounjaro is the right option.
Online consultation for Mounjaro — step by step
The consultation begins with a medical assessment. Any prescription depends on the indication and each patient’s situation.
Choose the service and book your appointment
Choose and pay for the online nutrition consultation. Once payment is confirmed, select an available calendar slot. The appointment is subsequently confirmed by the doctor; check your email and the status in your account.
Prepare for the consultation
Write down your weight, height and anything you consider relevant to your health.
Video consultation with Dr. Petrache
During the online consultation, Dr. Petrache will assess your health, discuss your goals, explain how Mounjaro works and its potential benefits and risks, and answer your questions.
Prescription and therapeutic plan
If you are eligible, you will receive the electronic medical prescription, dosing schedule, injection instructions and dietary recommendations that optimise treatment effectiveness.
Ongoing monitoring
The doctor will recommend a follow-up visit according to your goals.
How Mounjaro administration is determined
The dose, gradual escalation and duration of Mounjaro treatment are determined by the doctor according to the official information for the prescribed formulation and the individual response. A general schedule found online does not replace a prescription.
Do not change the dose or restart treatment after a break without your doctor’s recommendation. For a missed dose, follow the instructions in the leaflet for your exact medicine and ask your doctor or pharmacist for advice.
Side effects and warning signs
Mounjaro may cause digestive reactions such as nausea, diarrhoea, vomiting, constipation and abdominal pain. Frequency and severity vary with the medicine, population and dose; consult the current leaflet for the complete list.
Persistent or intense symptoms, repeated vomiting, inability to stay hydrated and severe abdominal pain require medical assessment. Seek immediate help for sudden loss or rapid worsening of vision. For breathing difficulties, facial swelling or other signs of an emergency, call 112.
Wegovy and Mounjaro: discussing the choice
Wegovy contains semaglutide, while Mounjaro contains tirzepatide. Both are authorised in the European Union for weight management in eligible people, alongside a reduced-calorie diet and physical activity.
Percentages from different studies do not predict individual results. The choice depends on the indication, medical history, tolerability and concomitant treatments. The doctor explains the options suitable for you.
For comparative data and their limitations, see the Wegovy vs Mounjaro guide.
Benefits of an online consultation with Dr. Petrache
Clinica Virtuală Dr. Petrache gives you access to modern obesity treatments in a convenient, professional and safe way:
Real medical expertise
Dr. Petrache, a doctor in diabetology and nutrition, reviews your medical history and discusses treatment options during the consultation.
Comprehensive medical assessment
We do more than provide prescriptions — every patient receives a thorough medical assessment that considers the full clinical picture: test results, comorbidities, current medication and realistic goals.
No travel, no waiting
The consultation takes place from home or anywhere with an internet connection. You save time, money and effort — especially if you live in an area without easy access to specialists.
Continuity of care
Dr. Petrache supports you throughout treatment, with regular monitoring consultations, dose adjustments and help with any questions or concerns.
Full confidentiality
Medical information is used to provide the service. Details about data processing and contact information are available in the privacy policy.
Frequently asked questions about Mounjaro
Is Mounjaro available in Romania?
Mounjaro is authorised in the European Union. Check with the pharmacy for the availability of the prescribed formulation and dose in Romania; authorisation does not guarantee stock availability.
How much weight can I lose with Mounjaro?
The response varies from person to person. Average study results depend on the population, dose and duration and do not guarantee the number of kilograms lost or the rate of weight loss. Goals and monitoring are agreed with the doctor.
Is Mounjaro more effective than Wegovy?
Comparative studies exist, but the average result does not determine which medicine is suitable for each patient. The doctor assesses the indication, medical history, tolerability and concomitant treatments.
Can I take Mounjaro if I have type 2 diabetes?
Yes, tirzepatide was initially approved specifically for treating type 2 diabetes. Mounjaro is particularly beneficial for patients who have both type 2 diabetes and overweight or obesity, because it treats both conditions simultaneously.
How often is the Mounjaro injection given?
Administer it according to the prescription and the instructions for the device dispensed. Ask your doctor or pharmacist to explain the technique; do not assume that all pens are prepared and used in the same way.
What side effects does Mounjaro have?
The most common side effects are gastrointestinal: nausea, diarrhoea, constipation and abdominal pain. These are usually mild and improve as the body gets used to treatment, particularly because the dose is increased gradually.
Can I take Mounjaro without a prescription?
Mounjaro is a prescription medicine. The consultation provides an assessment; a prescription is issued only if the doctor determines that treatment is indicated. The medicine is dispensed at a pharmacy under the applicable conditions.
How long does Mounjaro treatment last?
Mounjaro treatment is usually long term, as with treatment for any chronic condition. The exact duration is determined by the doctor according to your goals and progress. Stopping treatment may lead to regaining some of the weight lost.
Would you like to find out whether Mounjaro is right for you?
Request an online consultation with Dr. Petrache for an assessment and discussion of your options. A prescription is issued only if medically indicated.
Book a consultationOfficial information about Mounjaro
Indications, precautions and administration should be checked in the official medicine information and discussed with the doctor. Do not change the dose based on information on this page. Authorisation in the European Union does not guarantee availability in pharmacies in Romania.
European Medicines Agency — Mounjaro (in English)